Achillion Pharmaceuticals Inc 

ACHN:NASDAQ

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
7.77 0.21   2.78%0.00%823,358675.6K

Market data is delayed by at least 20 minutes.
Filing TypeFiling DateCategory
10-QMay 7, 2013Quarterly Financials
ARSApril 16, 2013Annual Report
DEF 14AApril 12, 2013Proxy Statement
3March 4, 2013New Insider
SC 13G/AFebruary 26, 2013>= 5% Acquisition
8-KFebruary 22, 2013Company Events
424B2February 22, 2013Prospectus
8-KFebruary 20, 2013Company Events
424B5February 20, 2013Prospectus
10-KFebruary 20, 2013Annual Financials
SC 13G/AFebruary 14, 2013>= 5% Acquisition
SC 13G/AFebruary 14, 2013>= 5% Acquisition
8-KFebruary 13, 2013Company Events
SC 13D/AJanuary 18, 2013SC 13D/A
4January 18, 2013Insider Buy/Sell
4January 18, 2013Insider Buy/Sell
4January 18, 2013Insider Buy/Sell
4January 18, 2013Insider Buy/Sell
4January 18, 2013Insider Buy/Sell
4January 18, 2013Insider Buy/Sell
 
 
 

Latest Annual and Quarterly SEC Filings

10-K
February 20, 2013
This report contains detailed information about the company's business finances and management.
10-Q
May 7, 2013
Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)